Halozyme Therapeutics, Inc. (HALO)
91.13
-1.91
(-2.05%)
USD |
NASDAQ |
Nov 20, 15:35
Halozyme Therapeutics 30-Day Average Daily Volume : 2.350M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.350M |
| November 18, 2026 | 2.303M |
| November 17, 2026 | 2.322M |
| November 16, 2026 | 2.313M |
| November 13, 2026 | 2.305M |
| November 12, 2026 | 2.316M |
| November 11, 2026 | 2.346M |
| November 10, 2026 | 2.380M |
| November 09, 2026 | 2.400M |
| November 06, 2026 | 2.377M |
| November 05, 2026 | 2.237M |
| November 04, 2026 | 2.246M |
| November 03, 2026 | 2.283M |
| November 02, 2026 | 2.371M |
| October 30, 2026 | 2.355M |
| October 29, 2026 | 2.648M |
| October 28, 2026 | 2.651M |
| October 27, 2026 | 2.651M |
| October 26, 2026 | 2.629M |
| October 23, 2026 | 2.619M |
| October 22, 2026 | 2.596M |
| October 21, 2026 | 2.475M |
| October 20, 2026 | 2.476M |
| October 19, 2026 | 2.459M |
| October 16, 2026 | 2.429M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.423M |
| October 14, 2026 | 2.394M |
| October 13, 2026 | 2.304M |
| October 12, 2026 | 2.288M |
| October 09, 2026 | 2.288M |
| October 08, 2026 | 2.272M |
| October 07, 2026 | 2.246M |
| October 06, 2026 | 2.227M |
| October 05, 2026 | 2.237M |
| October 02, 2026 | 2.214M |
| October 01, 2026 | 2.180M |
| September 30, 2026 | 2.187M |
| September 29, 2026 | 2.135M |
| September 28, 2026 | 2.112M |
| September 25, 2026 | 2.093M |
| September 24, 2026 | 2.094M |
| September 23, 2026 | 2.110M |
| September 22, 2026 | 2.114M |
| September 21, 2026 | 2.141M |
| September 18, 2026 | 2.301M |
| September 17, 2026 | 2.052M |
| September 16, 2026 | 2.028M |
| September 15, 2026 | 2.023M |
| September 14, 2026 | 2.034M |
| September 11, 2026 | 2.055M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Iovance Biotherapeutics, Inc. | 13.77M |
| AVITA Medical, Inc. | 538628.3 |
| Merck & Co., Inc. | 9.760M |
| TG Therapeutics, Inc. | 1.906M |
| Agenus, Inc. | 735450.1 |